VOYA Investment Management’s Niagen Bioscience NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,395
Closed -$207K 2681
2025
Q2
$207K Buy
14,395
+1,213
+9% +$12K ﹤0.01% 2312
2025
Q1
$91K Sell
13,182
-1,995
-13% -$12.5K ﹤0.01% 2452
2024
Q4
$80.5K Sell
15,177
-3,331
-18% -$18.2K ﹤0.01% 2623
2024
Q3
$67.6K Sell
18,508
-171
-0.9% -$538 ﹤0.01% 2738
2024
Q2
$51K Buy
+18,679
New +$62.5K ﹤0.01% 2789
2022
Q2
Sell
-17,907
Closed -$44K 2910
2022
Q1
$44K Hold
17,907
﹤0.01% 2609
2021
Q4
$67K Sell
17,907
-1,088
-6% -$5.87K ﹤0.01% 2723
2021
Q3
$119K Hold
18,995
﹤0.01% 2704
2021
Q2
$187K Buy
18,995
+1,333
+8% +$11.6K ﹤0.01% 2629
2021
Q1
$165K Sell
17,662
-423
-2% -$3.35K ﹤0.01% 2588
2020
Q4
$87K Buy
18,085
+3,686
+26% +$18K ﹤0.01% 2582
2020
Q3
$58K Hold
14,399
﹤0.01% 2421
2020
Q2
$66K Sell
14,399
-8,005
-36% -$35.8K ﹤0.01% 2405
2020
Q1
$73K Hold
22,404
﹤0.01% 2419
2019
Q4
$97K Buy
22,404
+6,414
+40% +$22.8K ﹤0.01% 2552
2019
Q3
$63K Sell
15,990
-3,035
-16% -$12.9K ﹤0.01% 2479
2019
Q2
$88K Buy
19,025
+3,363
+21% +$14.3K ﹤0.01% 2492
2019
Q1
$66K Sell
15,662
-4,429
-22% -$16K ﹤0.01% 2490
2018
Q4
$69K Hold
20,091
﹤0.01% 2454
2018
Q3
$86K Hold
20,091
﹤0.01% 2518
2018
Q2
$75K Buy
+20,091
New +$76.3K ﹤0.01% 2564

Other funds holding NAGE

VOYA Investment Management's NAGE Position: Q3 2025 in Review

VOYA Investment Management sold out of Niagen Bioscience (NAGE) in Q3 2025, closing a stake of 14,395 shares — an estimated $207K sold.

VOYA Investment Management first reported a position in NAGE in Q2 2018 and held it in 21 quarters. The position peaked at $207K in Q2 2025. 162 funds tracked by Wall St. Rank hold NAGE as of Q3 2025.

  • VOYA Investment Management reported no remaining Niagen Bioscience position as of Q3 2025 after selling out during the quarter.
  • VOYA Investment Management sold 14,395 Niagen Bioscience shares in Q3 2025, an estimated $207K.
  • VOYA Investment Management first reported a position in Niagen Bioscience in Q2 2018 and held it in 21 quarters.
  • VOYA Investment Management's Niagen Bioscience position peaked at $207K in Q2 2025.
  • 162 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2025.

Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.